{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:04:56Z","timestamp":1790636696812,"version":"4.1.0"},"reference-count":44,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1998,6,1]]},"DOI":"10.1136\/gut.42.6.761","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T12:46:12Z","timestamp":1277901972000},"page":"761-763","source":"Crossref","is-referenced-by-count":52,"title":["What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?"],"prefix":"10.1136","volume":"42","author":[{"given":"S A","family":"RILEY","sequence":"first","affiliation":[{"name":"Department of Gastroenterology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1998,6,1]]},"reference":[{"key":"2025121306532083000_42.6.761.1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.0954-6820.1942.tb06841.x","article-title":"Salazopyrin, a new sulfanilamide preparation.","volume":"110","author":"Svartz","year":"1942","journal-title":"Acta Med Scand"},{"key":"2025121306532083000_42.6.761.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(62)92080-9"},{"key":"2025121306532083000_42.6.761.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)63842-X"},{"key":"2025121306532083000_42.6.761.4","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM198012253032602","article-title":"Therapeutic efficacy of sulphasalazine and its metabolites in patients with ulcerative colitis and Crohn\u2019s disease.","volume":"303","author":"Klotz","year":"1980","journal-title":"N Engl J Med"},{"key":"2025121306532083000_42.6.761.5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.5.5.437"},{"key":"2025121306532083000_42.6.761.6","doi-asserted-by":"publisher","DOI":"10.1136\/gut.14.12.923"},{"key":"2025121306532083000_42.6.761.7","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296907"},{"key":"2025121306532083000_42.6.761.8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(77)90831-5","article-title":"An experiment to determine the active therapeutic moiety of sulphasalazine.","volume":"ii","author":"Azad Khan","year":"1977","journal-title":"Lancet"},{"key":"2025121306532083000_42.6.761.9","first-page":"551","article-title":"Sulphasalazine and the aminosalicylates in the treatment of inflammatory bowel disease.","volume":"75","author":"Riley","year":"1990","journal-title":"Q J Med"},{"key":"2025121306532083000_42.6.761.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-51-5-879"},{"key":"2025121306532083000_42.6.761.11","doi-asserted-by":"publisher","DOI":"10.1136\/gut.21.3.232"},{"key":"2025121306532083000_42.6.761.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6384.23"},{"key":"2025121306532083000_42.6.761.13","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199511000-00003"},{"key":"2025121306532083000_42.6.761.14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2036.1992.tb00561.x","article-title":"Improved maintenance of remission in ulcerative colitis by balsalazide 4g\/day compared with 2g\/day.","volume":"6","author":"Giaffer","year":"1992","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121306532083000_42.6.761.15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2036.1992.tb00578.x","article-title":"Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months.","volume":"6","author":"Green","year":"1992","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121306532083000_42.6.761.16","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.9.1282"},{"key":"2025121306532083000_42.6.761.17","first-page":"991","article-title":"Doudle-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis.","volume":"7","author":"Kruis","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025121306532083000_42.6.761.18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-7-199304010-00009"},{"key":"2025121306532083000_42.6.761.19","first-page":"1143","article-title":"Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomised double-blind study.","volume":"92","author":"d\u2019Albasio","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"2025121306532083000_42.6.761.20","first-page":"A736","article-title":"The effect of varying dose intervals of mesalamine enemas for the prevention of relapse in distal ulcerative colitis [abstract].","volume":"106","author":"Miner","year":"1994","journal-title":"Gastroenterology"},{"key":"2025121306532083000_42.6.761.21","doi-asserted-by":"publisher","DOI":"10.1007\/BF02047216"},{"key":"2025121306532083000_42.6.761.22","first-page":"S11","article-title":"Double-blind trial of 4.8g vs 2.4g of mesalazine for 4 weeks in the treatment of acute ulcerative colitis [abstract].","volume":"34","author":"Ahluwalia","year":"1993","journal-title":"Gut"},{"key":"2025121306532083000_42.6.761.23","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.6.775"},{"key":"2025121306532083000_42.6.761.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6520.599"},{"key":"2025121306532083000_42.6.761.25","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.8.929"},{"key":"2025121306532083000_42.6.761.26","first-page":"1867","article-title":"A double-blind comparison of oral versus rectal mesalazine versus combination therapy in the treatment of distal ulcerative colitis.","volume":"92","author":"Safdi","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"2025121306532083000_42.6.761.27","unstructured":"De Vos M (1992) Concentrations of 5-ASA and its major metabolite Ac-5-ASA in human intestinal biopsy homogenates [thesis]. (Univ of Ghent, Ghent)."},{"key":"2025121306532083000_42.6.761.28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2036.1993.tb00110.x","article-title":"The mode of action of aminosalicylates in inflammatory bowel disease.","volume":"7","author":"Greenfield","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121306532083000_42.6.761.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70627-4"},{"key":"2025121306532083000_42.6.761.30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/cs0780105","article-title":"Acetylation of 5-aminosalicylic acid by human colonic epithelial cells.","volume":"78","author":"Ireland","year":"1990","journal-title":"Clin Sci"},{"key":"2025121306532083000_42.6.761.31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2125.1991.tb03891.x","article-title":"Mesalazine release from coated tablets: effects of dietary fibre.","volume":"32","author":"Riley","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"2025121306532083000_42.6.761.32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2036.1988.tb00668.x","article-title":"Double-blind comparison of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid suppositories in patients with idiopathic proctitis.","volume":"2","author":"Van Hogezand","year":"1988","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121306532083000_42.6.761.33","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.10.1338"},{"key":"2025121306532083000_42.6.761.34","first-page":"A23","article-title":"Mucosal aminosalicylate levels correlate with clinical activity in patients with ulcerative colitis [abstract].","volume":"40","author":"Hussain","year":"1997","journal-title":"Gut"},{"key":"2025121306532083000_42.6.761.35","first-page":"A59","article-title":"Dose-loading with oral mesalazine: optimizing drug concentrations in the mucosa [abstract].","volume":"38","author":"Hussain","year":"1996","journal-title":"Gut"},{"key":"2025121306532083000_42.6.761.36","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.4.400"},{"key":"2025121306532083000_42.6.761.37","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3109\/00365528708991917","article-title":"Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides.","volume":"22","author":"Turunen","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"2025121306532083000_42.6.761.38","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0016-5085(88)90172-2","article-title":"Effect of disodium azodisalicylate on electrolyte transport in rabbit ileum and colon in vitro.","volume":"95","author":"Pamukcu","year":"1988","journal-title":"Gastroenterology"},{"key":"2025121306532083000_42.6.761.39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/00365529009091911","article-title":"Mesalazine: an overview of key preclinical studies.","volume":"172","author":"Bilyard","year":"1990","journal-title":"Scand J Gastroenterol Suppl"},{"key":"2025121306532083000_42.6.761.40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6634.1442"},{"key":"2025121306532083000_42.6.761.41","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.11.1599"},{"key":"2025121306532083000_42.6.761.42","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.6.761"},{"key":"2025121306532083000_42.6.761.43","doi-asserted-by":"crossref","first-page":"A786","DOI":"10.1016\/0016-5085(95)27454-5","article-title":"Renal function in patients with IBD on long term mesalazine Mz or olsalazine Oz [abstract].","volume":"108","author":"Bonnet","year":"1995","journal-title":"Gastroenterology"},{"key":"2025121306532083000_42.6.761.44","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.10.1348"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.42.6.761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T14:53:31Z","timestamp":1765637611000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.42.6.761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6,1]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1998,6,1]]},"published-print":{"date-parts":[[1998,6,1]]}},"alternative-id":["10.1136\/gut.42.6.761"],"URL":"https:\/\/doi.org\/10.1136\/gut.42.6.761","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6,1]]}}}